Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by carduon Nov 16, 2011 5:13pm
351 Views
Post# 19243093

RE: RE: RE: RE: Interesting Call

RE: RE: RE: RE: Interesting CallOVG1, I've noticed in some of your posts that you attribute comments made by me to: Singing, Gemini or whatever the h*ll his name is. To clear up the confusion I am the one who is critical of management and he (?) is the one who thinks that the sun shines out of BT"s a**.

As to the state of the SP of ONC I can only say that despite the abundance of positive news time and time again from the trials the price remains in the low $4s. Why is that? Could the market be saying, " we have no confidence in the management of this company despite the plethora of good news, you have still not completed enrollment in the Phase 3 despite saying that it would be done by now and timelines have been consistently thwarted."

Remember this, this treatment has been shown to be COMPLETELY safe, it has proven efficacy, it is in Phase 3 trials and it shows enormous promise. The SP should be sitting at $10+. But the market says NO. Singing can rationalize it anyway he (?) wants but the market is the final decider.

Despite the above I'm convinced one day we will be successful.
Bullboard Posts